These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7083622)

  • 1. Generalized argyria with low ceruloplasmin and copper levels in the serum. A case report with clinical and microscopical findings and a trial of penicillamine treatment.
    Johansson EA; Kanerva L; Niemi KM; Lakomaa EL
    Clin Exp Dermatol; 1982 Mar; 7(2):169-76. PubMed ID: 7083622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of argyria with penicillamin D].
    Lehnert W
    Dermatol Monatsschr; 1973 Dec; 159(12):1100-4. PubMed ID: 4802044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Correlation between serum copper level and enzymatic activity as well as the level of protein in ceruloplasmin].
    Rudy J; Bogdanikowa B
    Reumatologia; 1978; 16(1):13-9. PubMed ID: 674904
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of long-term penicillamine therapy on erythrocyte CuZn superoxide dismutase activity.
    Marklund SL; Ek B; Steen L
    Scand J Clin Lab Invest; 1984 Feb; 44(1):13-7. PubMed ID: 6701446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Penicillamine in the treatment of patients with systemic scleroderma].
    Gandzha IM
    Vrach Delo; 1987 May; (5):66-7. PubMed ID: 3617690
    [No Abstract]   [Full Text] [Related]  

  • 6. D-penicillamine and plasmapheresis in acute liver failure secondary to Wilson's disease.
    Rodríguez Fariña E; Tremosa Llurba G; Xiol Quingles X; Lores Obradors A; Castellote Alonso J; Gornals Soler JB; López Núñez C
    Rev Esp Enferm Dig; 2003 Jan; 95(1):60-2, 63-5. PubMed ID: 12760731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 3,3-dimethylcysteine (D-penicillamine) on serum copper in subjects with malignant disease [proceedings].
    Light PA; Preece AW; Evans PA
    Biochem Soc Trans; 1977; 5(5):1460-2. PubMed ID: 72695
    [No Abstract]   [Full Text] [Related]  

  • 9. [True hepatic Wilson's disease].
    Ciravegna B; Giacchino R; Marazzi MG
    Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary copper excretion in rheumatoid arthritis.
    McMurray W; Martin VM; Scudder P; Stocks J; White AG; Dormandy TL
    Ann Rheum Dis; 1975 Aug; 34(4):340-5. PubMed ID: 1190853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.
    Hefter H; Kuwert T; Herzog H; Arendt G; Stremmel W; Feinendegen LE
    J Neurol; 1993 Nov; 241(1):49-53. PubMed ID: 8138822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic and therapeutic aspects of Wilson's disease in the preclinical stage].
    Löbbner J; Bachmann H; Eichner B; Biesold D; Günther K
    Psychiatr Neurol Med Psychol (Leipz); 1973 May; 25(5):266-75. PubMed ID: 4203314
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
    Rosenberger K
    Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal abnormalities in heterozygotes for Wilson's disease: genes or copper?
    Strickland GT; Leu ML
    Am J Med Sci; 1972 Aug; 264(2):157-60. PubMed ID: 4653120
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary copper excretion before and after oral intake of d-penicillamine in parents of patients with Wilson's disease.
    Vieira J; Oliveira PV; Juliano Y; Warde KR; Deguti MM; Barbosa ER; Carrilho FJ; Cancado EL
    Dig Liver Dis; 2012 Apr; 44(4):323-7. PubMed ID: 22169274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceruloplasmin in Wilson's disease.
    Holtzman NA; Naughton MA; Iber FL; Gaumnitz BM
    J Clin Invest; 1967 Jun; 46(6):993-1002. PubMed ID: 6026104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal silver ingestion with copper and caeruloplasmin deficiency.
    Stepien KM; Taylor A
    Ann Clin Biochem; 2012 May; 49(Pt 3):300-1. PubMed ID: 22375039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma copper and antioxidant status in Wilson's disease.
    Ogihara H; Ogihara T; Miki M; Yasuda H; Mino M
    Pediatr Res; 1995 Feb; 37(2):219-26. PubMed ID: 7731761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease.
    Marecek Z; Heyrovský A; Volek V
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):292-6. PubMed ID: 1199668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased taste sensitivity after D-penicillamine reversed by copper administration.
    Henkin RI; Keiser HR; Jafee IA; Sternlieb I; Scheinberg IH
    Lancet; 1967 Dec; 2(7529):1268-71. PubMed ID: 4168610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.